|
1
|
Becker CM, Bokor A, Heikinheimo O, Horne
A, Jansen F, Kiesel L, King K, Kvaskoff M, Nap A, Petersen K, et
al: ESHRE guideline: Endometriosis. Hum Reprod Open.
2022:hoac0092022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kawahara N, Miyake R, Yamanaka S and
Kobayashi H: A novel predictive tool for discriminating
endometriosis associated ovarian cancer from ovarian endometrioma:
The R2 predictive index. Cancers (Basel). 13:38292021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mikhaleva LM, Davydov AI, Patsap OI,
Mikhaylenko EV, Nikolenko VN, Neganova ME, Klochkov SG,
Somasundaram SG, Kirkland CE and Aliev G: Malignant transformation
and associated biomarkers of ovarian endometriosis: A narrative
review. Adv Ther. 37:2580–2603. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sampson JA: Endometrial carcinoma of the
ovary, arising in endometrial tissue in that organ. Arch Surg.
10:1–72. 1925. View Article : Google Scholar
|
|
5
|
Yamaguchi K, Kitamura S, Furutake Y,
Murakami R, Yamanoi K, Taki M, Ukita M, Hamanishi J and Mandai M:
Acquired evolution of mitochondrial metabolism regulated by HNF1B
in ovarian clear cell carcinoma. Cancers (Basel). 13:24132021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leenen S, Hermens M, de Vos van Steenwijk
PJ, Bekkers RLM and van Esch EMG: Immunologic factors involved in
the malignant transformation of endometriosis to
endometriosis-associated ovarian carcinoma. Cancer Immunol
Immunother. 70:1821–1829. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang D, Guo C, Li Y, Zhou M, Wang H, Liu J
and Chen P: Oestrogen up-regulates DNMT1 and leads to the
hypermethylation of RUNX3 in the malignant transformation of
ovarian endometriosis. Reprod Biomed Online. 44:27–37. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murakami K, Kotani Y, Nakai H and
Matsumura N: Endometriosis-associated ovarian cancer: The origin
and targeted therapy. Cancers (Basel). 12:16762020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu H and Lang JH: Is abnormal eutopic
endometrium the cause of endometriosis? The role of eutopic
endometrium in pathogenesis of endometriosis. Med Sci Monit.
17:RA92–RA99. 2011.PubMed/NCBI
|
|
10
|
Murakami K, Kanto A, Sakai K, Miyagawa C,
Takaya H, Nakai H, Kotani Y, Nishio K and Matsumura N: Frequent
PIK3CA mutations in eutopic endometrium of patients with ovarian
clear cell carcinoma. Mod Pathol. 34:2071–2079. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Veronika V, Prisyazhnaya T, Zhamoydik VI,
Berlev IV and Malek A: Molecular-genetic background of
endometriosis: Diagnostic potential of heritable and expressed
factors. J Obstet Women's Dis. 67:64–73. 2018. View Article : Google Scholar
|
|
12
|
Li X, Zhang Y, Zhao L, Wang L, Wu Z, Mei
Q, Nie J, Li X, Li Y, Fu X, et al: Whole-exome sequencing of
endometriosis identifies frequent alterations in genes involved in
cell adhesion and chromatin-remodeling complexes. Hum Mol Genet.
23:6008–6021. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang B, Wang T, Li N, Zhang W and Hu Y:
The high expression of RRM2 can predict the malignant
transformation of endometriosis. Adv Ther. 38:5178–5190. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sampson JA: Perforating hemorrhagic
(chocolate) cysts of the ovary: Their importance and especially
their relation to pelvic adenomas of endometrial type (‘adenomyoma’
of the uterus, rectovaginal septum, sigmoid, etc.). Arch Surg.
3:245–323. 1921. View Article : Google Scholar
|
|
15
|
Jensen LJ, Kuhn M, Stark M, Chaffron S,
Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et
al: STRING 8-a global view on proteins and their functional
interactions in 630 organisms. Nucleic Acids Res. 37((Database
Issue)): D412–D416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen J, Xu D, Wang T, Yang Z, Yang Y, He K
and Zhao L: HMGB1 promotes the development of castration-resistant
prostate cancer by regulating androgen receptor activation. Oncol
Rep. 48:1972022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teng B, Zhao L, Gao J, He P, Li H, Chen J,
Feng Q and Yi C: 20(s)-Protopanaxadiol (PPD) increases the
radiotherapy sensitivity of laryngeal carcinoma. Food Funct.
8:4469–4477. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mishra A, Bharti AC, Saluja D and Das BC:
Transactivation and expression patterns of Jun and Fos/AP-1
super-family proteins in human oral cancer. Int J Cancer.
126:819–829. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cuylen S, Blaukopf C, Politi AZ,
Müller-Reichert T, Neumann B, Poser I, Ellenberg J, Hyman AA and
Gerlich DW: Ki-67 acts as a biological surfactant to disperse
mitotic chromosomes. Nature. 535:308–312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Y, Li J, Yang X, Song Y and Li H:
Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1)
promotes ovarian carcinogenesis by sponging microRNA-485-5p and
releasing DNA topoisomerase II alpha (TOP2A). Bioengineered.
12:12003–12022. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsuura S, Matsumoto Y, Morishima KI,
Izumi H, Matsumoto H, Ito E, Tsutsui K, Kobayashi J, Tauchi H,
Kajiwara Y, et al: Monoallelic BUB1B mutations and defective
mitotic-spindle checkpoint in seven families with premature
chromatid separation (PCS) syndrome. Am J Med Genet A. 140:358–367.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chan GK, Schaar BT and Yen TJ:
Characterization of the kinetochore binding domain of CENP-E
reveals interactions with the kinetochore proteins CENP-F and
hBUBR1. J Cell Biol. 143:49–63. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Paizula X, Mutailipu D, Xu W, Wang H and
Yi L: Identification of biomarkers related to tumorigenesis and
prognosis in breast cancer. Gland Surg. 11:1472–1488. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fu G, Ding X, Yuan K, Aikhionbare F, Yao
J, Cai X, Jiang K and Yao X: Phosphorylation of human Sgo1 by NEK2A
is essential for chromosome congression in mitosis. Cell Res.
17:608–618. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He D, Li T, Sheng M and Yang B:
Exonuclease 1 (Exo1) participates in mammalian non-homologous end
joining and contributes to drug resistance in ovarian cancer. Med
Sci Monit. 26:e9187512020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang S, Cai W, Li J, An W, Zheng H and
Liao M: Bioinformatics analysis and experimental study of
exonuclease 1 gene in lung adenocarcinoma. Biochem Genet.
60:1934–1945. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dracea A, Angelescu C, Danciulescu M,
Ciurea M, Ioana M and Burada F: Mismatch repair gene expression in
gastroesophageal cancers. Turk J Gastroenterol. 26:373–377. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Geng A, Qiu R, Murai K, Liu J, Wu X, Zhang
H, Farhoodi H, Duong N, Jiang M, Yee JK, et al: KIF20A/MKLP2
regulates the division modes of neural progenitor cells during
cortical development. Nat Commun. 9:27072018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Louw JJ, Nunes Bastos R, Chen X, Verdood
C, Corveleyn A, Jia Y, Breckpot J, Gewillig M, Peeters H, Santoro
MM, et al: Compound heterozygous loss-of-function mutations in
KIF20A are associated with a novel lethal congenital cardiomyopathy
in two siblings. PLoS Genet. 14:e10071382018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tian L, Goldstein A, Wang H, Ching Lo H,
Sun Kim I, Welte T, Sheng K, Dobrolecki LE, Zhang X, Putluri N, et
al: Mutual regulation of tumour vessel normalization and
immunostimulatory reprogramming. Nature. 544:250–254. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Folkman J: Angiogenesis: An organizing
principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao J, Klausen C, Yi Y, Cheng JC, Chang
HM and Leung PCK: Betacellulin enhances ovarian cancer cell
migration by up-regulating Connexin43 via MEK-ERK signaling. Cell
Signal. 65:1094392020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao Y, Li H, Han Q, Li Y, Wang T, Huang C,
Mao Y, Wang X, Zhang Q, Tian J, et al: Overexpression of DUSP6
enhances chemotherapy-resistance of ovarian epithelial cancer by
regulating the ERK signaling pathway. J Cancer. 11:3151–3164. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang S, Xie B, Wang L, Yang H, Zhang H,
Chen Y, Wang F, Liu C and He H: Macrophage-mediated vascular
permeability via VLA4/VCAM1 pathway dictates ascites development in
ovarian cancer. J Clin Invest. 131:e1403152021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koch A, Joosten SC, Feng Z, de Ruijter TC,
Draht MX, Melotte V, Smits KM, Veeck J, Herman JG, Van Neste L, et
al: Analysis of DNA methylation in cancer: Location revisited. Nat
Rev Clin Oncol. 15:459–466. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu XT, Xing W, Zhao RS, Tan Y, Wu XF, Ao
LQ, Li Z, Yao MW, Yuan M, Guo W, et al: HDAC2 inhibits EMT-mediated
cancer metastasis by downregulating the long noncoding RNA H19 in
colorectal cancer. J Exp Clin Cancer Res. 39:2702020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Koo JH, Plouffe SW, Meng Z, Lee DH, Yang
D, Lim DS, Wang CY and Guan KL: Induction of AP-1 by YAP/TAZ
contributes to cell proliferation and organ growth. Genes Dev.
34:72–86. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li P, Lin Z, Liu Q, Chen S, Gao X, Guo W,
Gong F, Wei J and Lin H: Enhancer RNA SLIT2 inhibits bone
metastasis of breast cancer through regulating P38 MAPK/c-Fos
signaling pathway. Front Oncol. 11:7438402021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Riedel M, Berthelsen MF, Cai H, Haldrup J,
Borre M, Paludan SR, Hager H, Vendelbo MH, Wagner EF, Bakiri L and
Thomsen MK: In vivo CRISPR inactivation of Fos promotes prostate
cancer progression by altering the associated AP-1 subunit Jun.
Oncogene. 40:2437–2447. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gupte R, Lin KY, Nandu T, Lea JS and Kraus
WL: Combinatorial treatment with PARP-1 inhibitors and cisplatin
attenuates cervical cancer growth through Fos-driven changes in
gene expression. Mol Cancer Res. 20:1183–1192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Matsuoka K, Bakiri L, Wolff LI, Linder M,
Mikels-Vigdal A, Patiño-García A, Lecanda F, Hartmann C, Sibilia M
and Wagner EF: Wnt signaling and Loxl2 promote aggressive
osteosarcoma. Cell Res. 30:885–901. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sohn JO, Seong SY, Kim HJ, Jo YM, Lee KH,
Chung MK, Song HJ, Park KS and Lim JM: Alterations in intracellular
Ca2+ levels in human endometrial stromal cells after
decidualization. Biochem Biophys Res Commun. 515:318–324. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zlatska AV, Rodnichenko AE, Gubar OS,
Zubov DO, Novikova SN and Vasyliev RG: Endometrial stromal cells:
Isolation, expansion, morphological and functional properties. Exp
Oncol. 39:197–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chiappini F, Bastón JI, Vaccarezza A,
Singla JJ, Pontillo C, Miret N, Farina M, Meresman G and Randi A:
Enhanced cyclooxygenase-2 expression levels and metalloproteinase 2
and 9 activation by Hexachlorobenzene in human endometrial stromal
cells. Biochem Pharmacol. 109:912016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu L, Chen G, Chen T, Shi W, Hu H, Song
K, Huang R, Cai H and He Y: si-SNHG5-FOXF2 inhibits TGF-β1-induced
fibrosis in human primary endometrial stromal cells by the
Wnt/β-catenin signalling pathway. Stem Cell Res Ther. 11:4792020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Choi Y, Rosewell KL, Brännström M, Akin
JW, Curry TE Jr and Jo M: FOS, a critical downstream mediator of
PGR and EGF signaling necessary for ovulatory prostaglandins in the
human ovary. J Clin Endocrinol Metab. 103:4241–4252. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pandey K, An HJ, Kim SK, Lee SA, Kim S,
Lim SM, Kim GM, Sohn J and Moon YW: Molecular mechanisms of
resistance to CDK4/6 inhibitors in breast cancer: A review. Int J
Cancer. 145:1179–1188. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu TZ, Chen CY, Yiin SJ, Chen CH, Cheng
JT, Shih MK, Wang YS and Chern CL: Molecular mechanism of cell
cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through
suppression of mitogen-activated protein kinase activation and
increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Food Chem Toxicol. 44:227–235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wu S, Wu Z, Xu H, Zhang J, Gu W, Tan X,
Pan Z, Cao D, Li D, Yang L, et al: miR-34a-5p inhibits the
malignant progression of KSHV-infected SH-SY5Y cells by targeting
c-fos. PeerJ. 10:e132332022. View Article : Google Scholar : PubMed/NCBI
|
